Market revenue in 2023 | USD 4.3 million |
Market revenue in 2030 | USD 9.0 million |
Growth rate | 11.1% (CAGR from 2023 to 2030) |
Largest segment | Inactivated (killed) |
Fastest growing segment | Other Vaccines |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Modified/ Attenuated Live, Inactivated (Killed), Other Vaccines |
Key market players worldwide | Zoetis, Phibro Animal Health Corp Class A, Elanco Animal Health Inc, Merck & Co Inc, Choong Ang Vaccine Laboratories (CAVAC), Kyoto Biken Laboratories, Nissenken, KBNP, Vaxxinova, HIPRA |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to aquaculture vaccines market will help companies and investors design strategic landscapes.
Inactivated (killed) was the largest segment with a revenue share of 34.88% in 2023. Horizon Databook has segmented the South Korea aquaculture vaccines market based on modified/ attenuated live, inactivated (killed), other vaccines covering the revenue growth of each sub-segment from 2018 to 2030.
Presence of key market players, technological advancements, and growing aquaculture sector are the main factors contributing to the South Korean Aquaculture Vaccines market. Koreans place a high value on origin, cost, and food safety which makes vaccination an important part of fish health protection strategy.
As per USDA’s Foreign Agricultural Service 2020 report on the Korea Seafood Market, the major species consumed in the country include shrimp, Alaska pollack, anchovy, oyster, squid, mackerel, tuna, flat fish, and octopus. Aquaculture industry is also driven by the restraints affecting capture fishing such as overfishing, increasing marine pollution, reclamation of coastal areas impacting fish habitats, and declining fishing grounds.
This has forced producers to increase yield in limited space while preventing overcrowding of fish. KBNP is a South Korean company that develops and markets vaccines, disinfectants, and other products for livestock, aquatic, and companion animals. The company’s Himmvac lineup of vaccines helps prevent streptococcosis in aquacultured fishes.
Horizon Databook provides a detailed overview of country-level data and insights on the South Korea aquaculture vaccines market , including forecasts for subscribers. This country databook contains high-level insights into South Korea aquaculture vaccines market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account